Stage 4 Survivor Now Fights for Cancer Research on Capitol Hill

When Ashleigh Parker sat across from her oncologist in 2019, she asked the question every cancer patient fears: "Am I going to die?" Today, cancer-free and full of purpose, she's fighting to make sure others never hear "it's too late."

The Olive Branch, Mississippi resident was just 48 when doctors found stage 4 colorectal cancer that had already spread to her liver. She'd dismissed her symptoms as normal aging, never imagining the battle ahead.

After years of surgeries, chemotherapy, and radiation, Parker reached the finish line. Now in the surveillance phase of recovery, she gets blood work every three months and scans every six months to watch for any return.

But Parker didn't stop at survival. She recently traveled to Washington D.C. with the American Cancer Society Cancer Action Network to meet with lawmakers during the federal budget process.

"I feel like where I am in my cancer journey, I've got the ability to go and speak for others who are sitting in the cancer chair," Parker said. She attended a Senate hearing and urged Congress to continue funding cancer research through the National Institutes of Health and National Cancer Institute.

The numbers back her up. According to the American Cancer Society Cancer Action Network, steady increases in research and prevention funding over the past three decades have contributed to a 34% decline in cancer mortality rates nationwide.

Parker credits those advancements with saving her life. "I think if I had been diagnosed 10 years ago, I probably wouldn't be here now," she said.

Why This Inspires

Parker's journey from patient to advocate shows how survivors are turning their second chances into action. The hardest moment of her cancer journey wasn't the diagnosis itself but telling her children. Now she channels that pain into helping others facing the same fear.

Her advocacy focuses on a simple but powerful idea: if patients can survive long enough, the next breakthrough might save their lives. Clinical trials and new treatments are constantly emerging, funded by the very programs she's fighting to protect.

Parker wants every cancer patient to know they're not alone. By sharing her story with both lawmakers and fellow survivors, she's building a bridge between research funding and real human lives.

Her message to Congress is clear: the investments work, and they're worth continuing. For the patients still in treatment, those dollars translate to hope, time, and possibility.